Regeneron Pharmaceuticals, Inc. (REGN)
638.88
-3.71
(-0.58%)
USD |
NASDAQ |
May 22, 16:00
642.41
+3.53
(+0.55%)
After-Hours: 06:14
Regeneron Pharmaceuticals Market Cap : 66.98B for May 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 183.12B |
| AbbVie, Inc. | 381.10B |
| Biogen, Inc. | 28.61B |
| Eli Lilly & Co. | 949.70B |
| Merck & Co., Inc. | 302.33B |
Market Cap Related Metrics
| PE Ratio | 15.57 |
| PS Ratio | 4.614 |
| PEG Ratio | 3.481 |
| Price to Book Value | 2.132 |
| Price to Free Cash Flow | 18.16 |
| Price | 638.88 |
| Earnings Yield | 6.42% |
| PEGY Ratio | 3.087 |
| Operating PE Ratio | 17.91 |
| Normalized PE Ratio | 15.40 |